Macitentan significantly
Xem 1-1 trên 1 kết quả Macitentan significantly
-
Macitentan is a dual endothelin receptor antagonist indicated for the long-term treatment of pulmonary arterial hypertension (PAH). We evaluated the change over time in REVEAL risk score in incident and prevalent patients receiving macitentan for the first time.
10p vimaine2711 26-03-2021 7 2 Download
CHỦ ĐỀ BẠN MUỐN TÌM
TOP DOWNLOAD